NPCE News and Press, Neuropace Inc. From 08/12/25

2025-08-12 21:51:27 ET More on NeuroPace NeuroPace, Inc. 2025 Q2 - Results - Earnings Call Presentation NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript NeuroPace: Volatile, Uncertain, But Promising NeuroPace secures $75M credit facility with MidCap Fi...

2025-08-12 21:50:30 ET NeuroPace, Inc. (NPCE) Q2 2025 Earnings Conference Call August 12, 2025 04:30 PM ET Company Participants Joel D. Becker - CEO, President & Director Patrick F. Williams - Chief Financial Officer Conference Call Participants Frank...

2025-08-12 16:15:47 ET More on NeuroPace NeuroPace: Volatile, Uncertain, But Promising NeuroPace secures $75M credit facility with MidCap Financial NeuroPace falls after setback in trial for neuromodulation system Seeking Alpha’s Quant Rating on NeuroP...

-- Reported record quarterly revenue of $23.5 million in Q2 2025-- -- Increased full-year 2025 revenue guidance to between $94 million and $98 million and gross margin guidance to between 75% and 76%-- -- Remain on track to submit NAUTILUS data to FDA for potential IGE indication ...

Reeds Inc. (REED) is expected to report $-0.04 for Q2 2025 Jerash Holdings (US) Inc. (JRSH) is expected to report for Q1 2026 Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2025-06-30 Verde Clean Fuels Inc. (VGAS) is expected to report for Q2 2025 Mobile In...

Neuropace Inc. (NPCE) is expected to report $-0.24 for Q2 2025

MOUNTAIN VIEW, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical technology company focused on transforming the lives of people living with epilepsy, today issued the following statement in response to the Centers for Medicare & Medicaid Services (CMS) electi...

MOUNTAIN VIEW, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the second quarter of 2025 after market close on Tuesday, August...

2025-06-29 16:00:00 ET In August of last year, I called NeuroPace ( NPCE ) a stock only suited for those with strong nerves. The company, which aims to improve lives of epilepsy patients with its RNS technology, helps patients in the drug-resistant epilepsy part of the mar...

2025-06-24 16:09:33 ET More on NeuroPace NeuroPace, Inc. (NPCE) Q1 2025 Earnings Call Transcript NeuroPace, Inc. 2025 Q1 - Results - Earnings Call Presentation NeuroPace secures $75M credit facility with MidCap Financial NeuroPace falls after setback in trial...